Trial reportScientific reports2025
Blue enriched light modulates pupil dilation induced by transcutaneous vagus nerve stimulation.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcutaneous vagus nerve stimulation (tVNS) targets the auricular branch of the vagus nerve and can modulate brainstem arousal systems, including the locus coeruleus-noradrenaline (LC-NE) pathway. Blue-enriched light also affects LC activity and can enhance alertness and cognition. However, no study has tested whether combining tVNS with blue light could further boost noradrenergic activity in humans. We therefore measured pupil responses, a well-established marker of LC-NE function, to assess how light and tVNS interact. We conducted a randomized, within-subject block design with twenty-five healthy adults (13 men, 12 women, aged 18-34) who received short (3.4 s) bursts of tVNS or sham stimulation (cymba conchae vs. earlobe). Pupil size was recorded under four light conditions: high intensity-blue, low intensity-blue, orange, and dim. TVNS increased pupil diameter relative to sham across all light conditions. Pupil dilation was largest and most sustained under low-blue light compared with dim or high-blue conditions. These results indicate that moderate tonic LC activation (e.g., low-blue light) enhances phasic responses to stimulation (e.g., tVNS), consistent with an inverted U-shaped relationship between tonic and phasic LC activity. Overall, our findings provide causal evidence that light, particularly low intensity-blue, modulates the effects of tVNS in humans, and combining both increases noradrenergic activity, as highlighted by increased pupil dilation, suggesting a simple way to enhance vagal-based therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.